Enzalutamide and CXCR7 inhibitor combination treatment suppresses cell growth and angiogenic signaling in castration‐resistant prostate cancer models
Yong Luo(Chinese Academy of Medical Sciences & Peking Union Medical College), Timothy C. Thompson(The University of Texas MD Anderson Cancer Center)
Cited by 50
Related Papers
Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches
|Oncogene|2013|879
Downregulation of transcription factor SOX2 in cancer stem cells suppresses growth and metastasis of lung cancer
|British Journal of Cancer|2011|173
Caveolin-1 regulates hormone resistance through lipid synthesis, creating novel therapeutic opportunities for castration-resistant prostate cancer
|Oncotarget|2016|29
β‑catenin nuclear translocation induced by HIF‑1α overexpression leads to the radioresistance of prostate cancer
|International Journal of Oncology|2018|29